Neurizon, Enters

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

Neurizon Therapeutics Limited Australia New York

en | boerse | 67940608 |